Plant-derived COVID-19 vaccine candidate starts rolling review with Health Canada
Medicago has started a rolling submission with Health Canada for its plant-derived adjuvanated COVID-19 vaccine candidate: championing a unique and versatile platform that can also be scaled up easily. The tech - which the company has honed over years with its influenza vaccine candidate - uses plants to produce protein particles for the vaccine. If authorized, the COVID-19 vaccine will become the company's first commercial product.
View the full story here: https://www.biopharma-reporter.com/Article/2021/04/27/Medicago-s-plant-based-COVID-19-vaccine-starts-Health-Canada-rolling-review?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright